Founded in Palo Alto, California, WGD Capital focuses on investing in early and expansion-stage private medical companies. The firm's core mission is to capitalize on rapidly evolving opportunities within the health and wellness market, particularly in the legal cannabis and psychedelic industries. Through its WGD Opportunity Fund, L.P., WGD Capital aims to support innovative ventures that are poised to make significant impacts in these specialized sectors.
Notable individuals affiliated with WGD Capital include experienced investors and industry experts who bring a wealth of knowledge to the firm. The company has successfully funded several pioneering companies in the health and wellness space, contributing to advancements in medical treatments and therapies. WGD Capital's strategic investments have positioned it as a key player in fostering growth and innovation within the legal cannabis and psychedelic markets.
